Refametinib
In Stock•Starting at $30 for 1 mg•Purity ≥ 99%
| CAS No. | 923032-37-5 |
|---|---|
| MDL No. | MFCD18633256 |
| MF | C19H20F3IN2O5S |
| MW | 572.30 |
| InChI Key | RDSACQWTXKSHJT-NSHDSACASA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $30 | In Stock | |
| 5 mg | 99% | $34 | In Stock | |
| 10 mg | 99% | $54 | In Stock | |
| 50 mg | 99% | $178 | In Stock | |
| 100 mg | 99% | $329 | In Stock |
Product Information
Refametinib is an orally bioavailable, selective MEK inhibitor with potential antineoplastic activity. It specifically inhibits MAP2K1 (MAPK/ERK kinase 1), thereby blocking growth factor-mediated cell signaling and tumor cell proliferation.
| CAS No. | 923032-37-5 |
|---|---|
| Product Name | Refametinib |
Biological Targets
MAP2K1·MAP2K2
Associated Conditions
hepatocellular carcinoma·biliary tract cancer·cancer·neoplasm
* The information provided here is compiled from public sources and is for reference only.